[Pathogen distribution and bacterial resistance in children with severe community-acquired pneumonia]

Yun-Yun Lu1, Rong Luo, Zhou Fu

  • 1Department of Respiratory Medicine, Children's Hospital of Chongqing Medical University, Chongqing 400014, China. luo_rong_512@aliyun.com.

Insights

Bacteria are the primary cause of severe community-acquired pneumonia (CAP) in children, with mixed infections being common. High rates of antibiotic resistance were observed in common bacterial pathogens.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Antimicrobial Resistance

Background:

  • Severe community-acquired pneumonia (CAP) poses a significant health threat to children worldwide.
  • Understanding the spectrum of pathogens and their antimicrobial susceptibility is crucial for effective treatment.

Purpose of the Study:

  • To determine the distribution of various pathogens causing severe CAP in hospitalized children.
  • To investigate the prevalence of bacterial resistance patterns in these pediatric CAP cases.

Main Methods:

  • A cohort of 522 children hospitalized with severe CAP in 2016 was analyzed.
  • Bacterial identification and antimicrobial susceptibility testing were performed using the phoenix-100 system.
  • Respiratory viruses, Mycoplasma pneumoniae (MP), and Chlamydia trachomatis (CT) were detected via direct immunofluorescence assay and quantitative real-time PCR.

Main Results:

  • Pathogens were identified in 80.3% of children, with mixed infections occurring in 45.3%.
  • Bacteria constituted the majority of identified pathogens (54.5%), followed by viruses (38.0%).
  • High drug-resistance rates were noted for Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Escherichia coli, and Klebsiella pneumoniae against common antibiotics, though sensitivity to specific agents was observed.

Conclusions:

  • Bacteria are the predominant pathogens in severe pediatric CAP, and mixed infections are frequent.
  • Significant antimicrobial resistance among key bacterial pathogens necessitates careful antibiotic selection for treating severe CAP in children.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
976
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
356
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.1K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.6K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
852
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.3K